SUSMED Co., Ltd. announced a private placement of non convertible preferred shares on May 11, 2020. The investment ratio is expected to be about 2.5-3.0% of the total number of issued shares. The transaction will include participation from new investor Suzuken Co., Ltd. (TSE:9987).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
572 JPY | -0.52% |
|
+7.52% | -57.15% |
2023 | SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index | CI |
2022 | Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.15% | 61.43M | |
-17.24% | 181B | |
+1.72% | 169B | |
+4.18% | 156B | |
+5.97% | 103B | |
+46.71% | 84.96B | |
+12.64% | 83.78B | |
-2.80% | 76.05B | |
-3.23% | 46.42B | |
-36.30% | 43.93B |
- Stock Market
- Equities
- 4263 Stock
- News SUSMED,Inc.
- SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.